Rallybio Corp (RLYB) Peer Comparison

$16.96

$0.17 (1.01%)

As on 01-Sep-2026 10:37EDT

Market cap

$89 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

2.1

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	89	16,765	16,261	13,492	11,994
Revenue ($ Mln)	1	2,782	1,054	2,436	670
Net Profit ($ Mln)	45.55	491.50	755.85	860.62	-319.95
Net Margin (%)	7,051.24	17.67	71.69	35.33	-47.79
RoE (%)	59.76	110.09	--	42.98	-71.14
Price to Earnings	2.10	35.25	19.00	17.40	--
Price-To-Book	0.94	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.65	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	7.80	1,982.07	103.47	85.67	19.14
Gross Profit	0.77	760.62	588.53	2,236.43	829.45
Operating Expenses	16.57	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-23.72	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	46.88	598.92	101.11	1,035.47	-252.08
Provision for Tax	1.32	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	45.55	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	94.50	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	0.00	187.89	384.48	288.55	1,362.63
Current Liabilities	3.57	1,435.43	464.70	361.93	283.35
Total Liabilities	62.26	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	0.81	1,006.90	895.24	1,243.41	440.60
Current Assets	97.25	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	62.26	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	0.00	120.10	449.89	165.93	864.07
Net Current Assets	93.69	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-29.81	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	47.27	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	0.02	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-14.97	53.56	-30.01	32.82	-0.17
ROE (%)	59.76	110.09	163.18	42.98	-71.14
ROA (%)	57.78	15.64	26.53	29.32	-16.12
EBIT Margin (%)	4,167.03	21.13	5.73	31.04	-0.77
Net Margin (%)	7,051.24	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.16	0.00	0.00	0.00	0.00

Growth Ratios

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-15.11	24.67	114.85	9.23	12.22
EBIT Growth (%)	162.02	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	209.36	17.50	378.76	42.89	-115.58
EPS Growth (%)	204.82	26.84	353.27	50.42	-73.87
Book Value Growth (%)	98.75	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-0.40	36.06	-59.76	15.79	-2,869.63
Price / Book Value	0.06	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	1.82	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.09
Current Ratio	27.26	0.73	2.99	3.46	5.90
Quick Ratio	27.26	0.73	2.32	3.38	5.90
Interest Coverage	--	--	1.62	--	-1.72

Operating Efficiency Ratios

	Rallybio Corp (RLYB)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	0.00	15.88	21.25	13.74	1.28
Asset Turnover	0.01	0.89	0.37	0.83	0.34
Receivable days	--	50.42	85.52	43.48	1.50
Inventory Days	--	--	1,056.70	96.17	--
Payable days	801.96	6.26	331.01	147.97	221.81
Cash Conversion Cycle	--	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly